Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Human Papillomavirus
Open-data reference.
13 US clinical trials · 4 currently recruiting
Active & Recent Trials
Provider Recommendation and HPV Vaccination
Kaiser Permanente
NCT05365048
Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
National Institute of Allergy and Infectious Diseases (NIAID)
NCT05026138
Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
The University of Texas Medical Branch, Galveston
NCT05672927
Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
M.D. Anderson Cancer Center
NCT06434337
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
National Cancer Institute (NCI)
NCT04708470
Longitudinal Clinical Evaluation of the HPV Assay on the BD VIPER LT System With Cervical Specimens
Becton, Dickinson and Company
NCT02267876
A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
The Center for the Biology of Chronic Disease
NCT02715752
Natural History of HPV From Infection to Neoplasia in Adolescents and Young Women
University of California, Los Angeles
NCT01366742
Human Papillomavirus (HPV) Vaccination Among Survivors of Childhood Cancer
St. Jude Children's Research Hospital
NCT01117389
txt2protect: Using Text Messaging to Increase HPV Vaccination Among Young Sexual Minority Men
Northwestern University
NCT02994108
Study of Gardasil in Mid-Adult Males (MAM)
H. Lee Moffitt Cancer Center and Research Institute
NCT01432574
Video to Promote HPV Vaccination
Children's Hospital of Philadelphia
NCT02196454
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
Icahn School of Medicine at Mount Sinai
NCT01358097
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Human Papillomavirus Trial Landscape
ClinicalTrials.gov lists 13 US studies indexed under Human Papillomavirus, and 4 of those are currently open to recruitment — roughly 31% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Human Papillomavirus shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 2 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Human Papillomavirus is led by The Center for the Biology of Chronic Disease with 1 indexed trial, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 13 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Human Papillomavirus?
PlainTrial tracks 13 US clinical trials for Human Papillomavirus, of which 4 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Human Papillomavirus?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.